...
首页> 外文期刊>Neurological Research: An Interdisciplinary Quarterly Journal >Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates.
【24h】

Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates.

机译:高渗盐溶液可控制对甘露醇和巴比妥类药物有过度反应的患者的颅内压升高。

获取原文
获取原文并翻译 | 示例
           

摘要

Critically elevated intracranial pressure (ICP) represents the most important cause of morbidity and mortality in patients suffering from severe traumatic brain injury (TBI) and is a serious complication after subarachnoid hemorrhage (SAH). Thus new strategies for the control of ICP are required. Based on the evidence available hypertonic saline solution (HSS) may be a promising approach. It was therefore the aim of the present study to evaluate in a prospective manner the effects of HSS on ICP and cerebral perfusion pressure (CPP) in patients with therapy-resistant elevation of ICP. A total of 48 bolus infusions of HSS (7.5%, 2 ml kg-1 b.w.; infusion rate 20 ml min-1) were given intravenously (range 1-15 per patient) to 10 patients (age 41 +/- 6 years) with TBI and SAH. Only patients with ICP > 25 mmHg not responding to standard ICP-management protocol and plasma sodium (Na+) concentration < 150 mmol l-1 were included in the study. Within the first hour after HSS application, ICP decreased from 33 +/- 9 mmHg to 19 +/- 6 mmHg (p < 0.05) and further to 18 +/- 5 mmHg at the time of maximum effect (98 +/- 11 min post bolus). Decrease of ICP was accompanied by a rise of CPP from 68 +/- 11 mmHg to 79 +/- 11 mmHg (p < 0.05) after 1 h and further to 81 +/- 11 mmHg at the time of maximum effect. Plasma Na+ concentration was 141 +/- 6 mmol l-1 before and 143 +/- 5 mmol l-1 1 h after HSS bolus. Corresponding values for plasma osmolality were 302 +/- 11 and 308 +/- 12 mOsm l-1. When the ICP lowering effect was transient, subsequent HSS bolus was necessary 163 +/- 54 min after previous dosing. The present results indicate that repeated bolus application of HSS (7.5% NaCl, 2 ml kg-1 b.w.) is an effective measure to decrease ICP which is otherwise refractory to standard therapeutic approaches. Whether or not the therapy scheme is also suited as primary measure for the control of ICP remains to be established.
机译:颅内压(ICP)严重升高是严重颅脑外伤(TBI)患者发病和死亡的最重要原因,并且是蛛网膜下腔出血(SAH)后的严重并发症。因此,需要用于控制ICP的新策略。根据证据,高渗盐溶液(HSS)可能是一种有前途的方法。因此,本研究的目的是以前瞻性的方式评估HSS对ICP耐治疗性升高的患者ICP和脑灌注压(CPP)的影响。对10例患者(41 +/- 6岁)进行了48次HSS推注输注(7.5%,2 ml kg-1 bw;输注速率20 ml min-1)(每位患者1-15)与TBI和SAH合作。本研究仅包括ICP> 25 mmHg且对标准ICP管理方案无反应且血浆钠(Na +)浓度<150 mmol l-1的患者。在应用HSS后的第一个小时内,ICP从33 +/- 9 mmHg降至19 +/- 6 mmHg(p <0.05),并在达到最大效果时进一步降至18 +/- 5 mmHg(98 +/- 11)分钟后推注)。 ICP的降低伴随着CPP在1小时后从68 +/- 11 mmHg升高到79 +/- 11 mmHg(p <0.05),并在达到最大作用时进一步升高到81 +/- 11 mmHg。 HSS推注之前和之后1 h血浆Na +浓度分别为141 +/- 6 mmol l-1和143 +/- 5 mmol l-1。血浆渗透压的相应值为302 +/- 11和308 +/- 12mOsm-1。当ICP降低的作用是短暂的时,在先前给药后163 +/- 54分钟必须进行随后的HSS推注。目前的结果表明,重复推注HSS(7.5%NaCl,2 ml kg-1 b.w.)是降低ICP的有效措施,而ICP对标准治疗方法是难以忍受的。该治疗方案是否也适合作为控制ICP的主要措施尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号